Active Shortage

CIPROFLOXACIN INTRAVENOUS INFUSION, BP

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CIPROFLOXACIN INTRAVENOUS INFUSION, BP in Canada?

Yes. CIPROFLOXACIN INTRAVENOUS INFUSION, BP 2MG has an active shortage reported to Health Canada (last updated October 5, 2017).

Why is CIPROFLOXACIN INTRAVENOUS INFUSION, BP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will CIPROFLOXACIN INTRAVENOUS INFUSION, BP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file6 products · 0 same form & route

Affected strength2MG

Report last updated2017-10-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SANDOZ CIPROFLOXACIN

SANDOZ CANADA INCORPORATED

250MG · DIN 02248756

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

RIVA-CIPROFLOXACIN

LABORATOIRE RIVA INC.

500MG · DIN 02251248

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

JAMP-CIPROFLOXACIN

JAMP PHARMA CORPORATION

250MG · DIN 02380358

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CIPROFLOXACIN

SANIS HEALTH INC

500MG · DIN 02353326

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

MAR-CIPROFLOXACIN

MARCAN PHARMACEUTICALS INC

500MG · DIN 02379694

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ACT CIPROFLOXACIN

TEVA CANADA LIMITED

250MG · DIN 02247339

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02304546

Strength

2MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

CIPROFLOXACIN

Tier

Unrated

Last Updated

2017-10-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244

10MG · DIN 02240414

20MG · DIN 02296098

150MG · DIN 02296160

75MG · DIN 02230507

2MG · DIN 02554178

2MG · DIN 02554194